|
|
||||||||
1 GlaxoSmithKline, Harlow, Essex CM19 5AW, UK
2 GlaxoSmithKline, King of Prussia, Pennsylvania 19406, USA
3 Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, UK
Reprint requests to: Kathrine J. Smith, GlaxoSmithKline, NFSP (N), Structural Biology Group, CASS, Third Avenue, Harlow, Essex CM19 5AW, UK; e-mail: Kathrine_J_Smith{at}gsk.com; fax: 44 (0) 1279 627896.
Polypeptide deformylase (PDF) catalyzes the deformylation of polypeptide chains in bacteria. It is essential for bacterial cell viability and is a potential antibacterial drug target. Here, we report the crystal structures of polypeptide deformylase from four different species of bacteria: Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Escherichia coli. Comparison of these four structures reveals significant overall differences between the two Gram-negative species (E. coli and H. influenzae) and the two Gram-positive species (S. pneumoniae and S. aureus). Despite these differences and low overall sequence identity, the S1' pocket of PDF is well conserved among the four enzymes studied. We also describe the binding of nonpeptidic inhibitor molecules SB-485345, SB-543668, and SB-505684 to both S. pneumoniae and E. coli PDF. Comparison of these structures shows similar binding interactions with both Gram-negative and Gram-positive species. Understanding the similarities and subtle differences in active site structure between species will help to design broad-spectrum polypeptide deformylase inhibitor molecules.
Keywords: PDF; deformylase; crystal structure; Escherichia coli; Haemophilus influenzae; Staphylococcus aureus; Streptococcus pneumoniae
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Saxena, P. Kanudia, M. Datt, H. H. Dar, S. Karthikeyan, B. Singh, and P. K. Chakraborti Three Consecutive Arginines Are Important for the Mycobacterial Peptide Deformylase Enzyme Activity J. Biol. Chem., August 29, 2008; 283(35): 23754 - 23764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, G. S. Van Aller, A. N. Taylor, J. J. Kerrigan, W.-S. Liu, J. M. Trulli, Z. Lai, D. Holmes, K. M. Aubart, J. R. Brown, et al. Phylogenomic and Biochemical Characterization of Three Legionella pneumophila Polypeptide Deformylases. J. Bacteriol., July 1, 2006; 188(14): 5249 - 5257. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Watters, R. N. Jones, J. A. Leeds, G. Denys, H. S. Sader, and T. R. Fritsche Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004) J. Antimicrob. Chemother., May 1, 2006; 57(5): 914 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Kudva, R. W. Griffin, J. M. Garren, S. B. Calderwood, and M. John Identification of a Protein Subset of the Anthrax Spore Immunome in Humans Immunized with the Anthrax Vaccine Adsorbed Preparation Infect. Immun., September 1, 2005; 73(9): 5685 - 5696. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |